NMDA receptor blockade augmented nicotine-evoked dopamine release from rat prefrontal cortex slices

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Nicotine activates nicotinic acetylcholine receptors, increasing dopamine release.
• Schizophrenia is linked to higher smoking rates and altered dopamine/glutamate circuits.
• NMDA receptor blockade models schizophrenia symptoms.

Purpose of the Study:

• To investigate the effect of ketamine on nicotine-induced dopamine release in rat prefrontal cortex.
• To explore the potential role of nicotinic acetylcholine receptors in schizophrenia pathophysiology and treatment.

Main Methods:

• Used a slice superfusion assay with rat prefrontal cortex slices.
• Slices were preloaded with radiolabeled dopamine ([ (3)H] dopamine).
• Examined the impact of various ketamine and nicotine concentrations.

Main Results:

• Ketamine alone did not induce dopamine release.
• Ketamine (1-10 microM) augmented nicotine's (1-100 microM) dopamine release effect.
• Ketamine decreased the threshold nicotine concentration for dopamine release, indicating increased nicotine potency and efficacy.

Conclusions:

• NMDA receptor blockade by ketamine enhances nicotine's effect on dopamine release.
• Ketamine appears to induce hypersensitivity to nicotine in the prefrontal cortex.
• Findings support the involvement of nicotinic acetylcholine receptors in schizophrenia.